The global bone cement industry was valued at USD 657.8 million in 2024 and is projected to surpass USD 1.2 billion by the end of 2035. The market is expected to grow at a CAGR of 5.2% from 2025 to 2035, supported by the rising number of orthopedic procedures, increasing prevalence of joint disorders, and growing adoption of advanced biomaterials in joint replacement surgeries.

Transform Your Strategy: Explore In-Depth Data – Sample Available! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86511

Market Overview

Bone cement is a biomedical device most commonly used in orthopedic surgery to stabilize implants to bone and fill defects or voids within bone structures. Polymethyl methacrylate (PMMA) is one of the primary ingredients of bone cement, which offers mechanical strength and durability. It is noteworthy that the most utilized type of bone cement is conventional bone cement, which has multiple applications across a wide range of surgical procedures, including joint replacement arthroplasties. Conventional bone cement has excellent adhesive strength and endurance for mechanical load applied over a joint.

On the other hand, antibiotic-loaded bone cement is endowed with antibiotics that are incorporated into avert infection following the procedure, used optimally for candidates with higher infection risk. Additionally, modern-day bioactive bone cements aim to achieve maximum bone integration and healing by delivering bioactive agents to augment osteoconduction and induce bone regeneration.

Analysts’ Viewpoint on the Global Bone Cement Market

Rising prevalence of osteoarthritis, osteoporosis, and fractures, advancements in surgical techniques, growing geriatric population, and continuous research and development in bone cement formulations are factors driving the growth of bone cement market.

Further, the increasing incidence of sports-related injuries and accidents contributes to the demand for orthopedic surgeries, which, in turn, propels the bone cement industry. As manufacturers are expanding their product offerings through launch of enhanced bone cement formulations, healthcare providers are increasingly drawn to utilize such products for providing optimal patient care.

The major companies are increasingly focusing on the development of antibiotic-loaded bone cements, which is known to mitigate risks associated with post-operative infections. Further, the creation of bioactive bone cements that stimulate bone growth and integration is accelerating, which is looked upon as a shift toward functional and effective product.

Analysis of Key Players in the Bone Cement Market

The market is moderately concentrated, with long-standing orthopedic giants leveraging their implant portfolios to “bundle” cement products.

Leading companies operating in the global bone cement market include:

• Stryker
• DePuy Synthes (Johnson & Johnson)
• Cardinal Health
• Heraeus Medical GmbH
• Exactech, Inc.
• Zimmer Biomet
• Enovis Corporation
• Smith+Nephew
• Medtronic
• Olympus Corporation
• Tecres SpA
• Slaney Healthcare
• Evolutis
• IZI Medical Products
• OSARTIS GmbH

Strategic M&A is rampant; notably, DePuy Synthes’ 2024 acquisition of Italy-based Tecres has consolidated their grip on the European “space-maker” and cement markets.

Recent Developments in Bone Cement Market

• In March 2025, Zimmer Biomet announced the launch of its Tekcem 1G and Tekcem 3G antibiotic bone cements in India. These cements are manufactured by Teknimed and are designed for prosthesis fixation in arthroplasty procedures, joint reconstruction after trauma, and both primary and revision surgeries. Some of the unique characteristics of these cements include gentamicin incorporation for superior bacterial defence, specialized formulation to lower monomer release, reduce toxicity and shrinkage, enhance implant fixation, and minimize the risk of monomer shock.
• In April 2024, OsteoRemedies LLC announced that it received the U.S. FDA’s clearance for expanded indications for the SPECTRUM GV Bone Cement. The expanded indication covers the fixation of revision hip arthroplasty components, implanted in the second stage of a two-stage revision after the initial infection.

Key Developments in the Bone Cement Market

• Nano-Doping for Radiopacity: Integration of nano-tantalum carbide to improve X-ray visibility without compromising mechanical strength.
• Low-Exotherm Formulations: Development of cements that set at lower temperatures to prevent thermal necrosis (bone death caused by chemical heat).
• 3D-Printed Spacers: Use of patient-specific 3D-printed molds for custom antibiotic-cement mixes in complex revision cases.
• Biodegradable Alternatives: Rising R&D into calcium phosphate and magnesium-based cements that are eventually replaced by natural bone.

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=86511&ltype=S

Challenges & Opportunities

Challenges:

• Cementless Implants: Growing preference for press-fit cementless joints among younger patients.
• Thermal Necrosis: Risk of tissue damage from the high-heat curing process of PMMA.
• Regulatory Hurdles: Stringent FDA and MDR (Europe) requirements for new antibiotic combinations.

Opportunities:

• Geriatric Arthroplasty: Aging global population ensures strong baseline demand.
• Bio-inductive Coatings: Development of cements that release growth factors to accelerate healing.
• Emerging Markets: High CAGR potential in Asia-Pacific driven by healthcare infrastructure expansion in India and China.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com